These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 4981700
1. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia]. Mokeeva RA, Zhuravlev VS. Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700 [No Abstract] [Full Text] [Related]
2. [Plasmapheresis and hyperviscosity syndrome]. Corral Alonso M, Barbolla ML. Sangre (Barc); 1984 Mar; 29(5):940-50. PubMed ID: 6441295 [No Abstract] [Full Text] [Related]
4. [Hyperviscosity syndrome]. Dumas G, Merceron S, Zafrani L, Canet E, Lemiale V, Kouatchet A, Azoulay E. Rev Med Interne; 2015 Sep; 36(9):588-95. PubMed ID: 25778852 [Abstract] [Full Text] [Related]
5. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange]. Malecaze F, Mathis A, Gonzales C, Lloveras JJ, Goudable C, Arlet P, Bec P. J Fr Ophtalmol; 1986 Sep; 9(5):367-71. PubMed ID: 3100607 [Abstract] [Full Text] [Related]
6. [Therapeutic effects of plasmapheresis in Waldenström's disease]. Moulinier J, Servantie X, Mesnier F. J Med Bord; 1967 Sep; 144(9):1295-300. PubMed ID: 4988704 [No Abstract] [Full Text] [Related]
7. Therapeutic plasmapheresis in treatment of patients with Waldenström's macroglobulinemia. Lawson NS, Nosanchuk JS, Oberman HA, Meyers MC. Transfusion; 1968 Sep; 8(3):174-8. PubMed ID: 4968993 [No Abstract] [Full Text] [Related]
8. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome]. Amamiya Y, Baba M, Hisamitsu J, Ito T, Amaki T. Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174 [No Abstract] [Full Text] [Related]
12. Role of plasmapheresis in Waldenström's macroglobulinemia. Stone MJ, Bogen SA. Clin Lymphoma Myeloma Leuk; 2013 Apr 23; 13(2):238-40. PubMed ID: 23522642 [Abstract] [Full Text] [Related]
13. [Myeloma and Waldenström's macroglobulinemia]. Palva I. Duodecim; 1989 Apr 23; 105(11):1088-94. PubMed ID: 2502371 [No Abstract] [Full Text] [Related]
14. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia. Menke MN, Feke GT, McMeel JW, Treon SP. Invest Ophthalmol Vis Sci; 2008 Mar 23; 49(3):1157-60. PubMed ID: 18326744 [Abstract] [Full Text] [Related]
15. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström's macroglobulinemia. Somer T, Ditzel J. Bibl Haematol; 1981 Mar 23; (47):242-6. PubMed ID: 6802129 [No Abstract] [Full Text] [Related]
16. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases. Mód A, Füst G, Harsányi V, Natonek K, Poros A, Szabó J, Hollán SR. Haematologia (Budap); 1981 Mar 23; 14(1):49-56. PubMed ID: 6454615 [Abstract] [Full Text] [Related]
17. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation. Reinhart WH, Lutolf O, Nydegger UR, Mahler F, Straub PW. J Lab Clin Med; 1992 Jan 23; 119(1):69-76. PubMed ID: 1727909 [Abstract] [Full Text] [Related]